NCT01314898 A Single Dose Study Of Antimineralocorticoid Activity Of PF-03882845 In Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01314885 Single Dose Lipopolysaccharide (LPS) Study In Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01313793 A Bioequivalence (BE) Study Comparing The Commericializable And Clinical Formulations Of PF-00299804 Status COMPLETED Phase PHASE1
NCT01311505 Bioequivalence Study Comparing Rifampicin In A Fixed-Dose Combination (Rifampicin+Isoniazid, Myrin© 2) And The Reference Drug (Rifampicin, Rimactane®) Status COMPLETED Phase PHASE1
NCT01309737 A One-Year Study To Evaluate The Efficacy And Safety Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT01309542 Long-Term Safety Of DVS-233 SR In Patients With Major Depressive Disorder Status COMPLETED Phase PHASE3
NCT01308736 Varenicline-Aided Cigarette Reduction in Smokers Not Ready to Quit Status COMPLETED Phase NA
NCT01307267 A Study Of PF-05082566 As A Single Agent And In Combination With Rituximab Status COMPLETED Phase PHASE1
NCT01305239 A Survey Of Clinical Practice Of Adjuvant Treatment Of Breast Cancer Using Exemestane (Aromasin®) In Postmenopausal Hr+ Patients Status TERMINATED Phase N/A
NCT01303549 Anidulafungin vs Amphotericin B Safety in High Risk Hepatic Transplant Recipients Status COMPLETED Phase PHASE4
NCT01302262 Smoking-induced Dopamine Release: a [11C]-(+)-PHNO PET Study in Humans Status COMPLETED Phase N/A
NCT01302119 Efficacy and Safety of AN2690 Topical Solution to Treat Onychomycosis of the Toenail Status COMPLETED Phase PHASE3
NCT01302067 A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine Status COMPLETED Phase PHASE4
NCT01302054 A Clinical Study in Patients With Overactive Bladder With Leakage of Urine, to Find Out if the Medicine, Fesoterodine, Works in Those Patients Who Did Not Have Enough Response to the Medicine, Tolterodine. Status COMPLETED Phase PHASE4
NCT01301508 Efficacy and Safety of AN2898 and AN2728 Topical Ointments to Treat Mild-to-Moderate Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT01301456 Single-Dose And Multiple-Dose Safety And Tolerability Study Of PF-04856883 In Type 2 Diabetic Adult Females Status COMPLETED Phase PHASE1
NCT01300052 AN2728 Topical Ointment to Treat Mild-to-Moderate Plaque-Type Psoriasis Status COMPLETED Phase PHASE2